Synthetic lethality-based prediction of anti-SARS-CoV-2 targets.

Drugs Synthetic biology Virology

Journal

iScience
ISSN: 2589-0042
Titre abrégé: iScience
Pays: United States
ID NLM: 101724038

Informations de publication

Date de publication:
20 May 2022
Historique:
received: 16 07 2021
revised: 19 10 2021
accepted: 04 04 2022
pubmed: 4 5 2022
medline: 4 5 2022
entrez: 3 5 2022
Statut: ppublish

Résumé

Novel strategies are needed to identify drug targets and treatments for the COVID-19 pandemic. The altered gene expression of virus-infected host cells provides an opportunity to specifically inhibit viral propagation via targeting the synthetic lethal and synthetic dosage lethal (SL/SDL) partners of such altered host genes. Pursuing this disparate antiviral strategy, here we comprehensively analyzed multiple

Identifiants

pubmed: 35502318
doi: 10.1016/j.isci.2022.104311
pii: S2589-0042(22)00582-X
pmc: PMC9044693
doi:

Banques de données

figshare
['10.6084/m9.figshare.12436517']

Types de publication

Journal Article

Langues

eng

Pagination

104311

Subventions

Organisme : NIAID NIH HHS
ID : U19 AI118610
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI135972
Pays : United States

Commentaires et corrections

Type : UpdateOf

Déclaration de conflit d'intérêts

E.R. is a co-founder of Medaware, Metabomed, and Pangea Therapeutics (divested from the latter). E.R. serves as a nonpaid scientific consultant to Pangea Therapeutics, a company developing a precision oncology SL-based multi-omics approach. The other authors declare no competing interests.

Références

J Virol. 2020 Jun 16;94(13):
pubmed: 32546606
N Engl J Med. 2021 Feb 11;384(6):497-511
pubmed: 33264556
Cell. 2021 Jan 7;184(1):106-119.e14
pubmed: 33333024
J Cell Biol. 2008 Apr 21;181(2):293-307
pubmed: 18426977
J Proteome Res. 2020 Nov 6;19(11):4233-4241
pubmed: 32914632
Cell. 2021 Jan 7;184(1):76-91.e13
pubmed: 33147444
Signal Transduct Target Ther. 2021 May 18;6(1):198
pubmed: 34006835
Sci Adv. 2021 Jan 1;7(1):
pubmed: 33523837
J Pharm Pract. 2022 Aug;35(4):654-660
pubmed: 33719699
Nat Biotechnol. 2020 Aug;38(8):970-979
pubmed: 32591762
J Virol. 2011 Dec;85(24):12939-49
pubmed: 21976648
J Infect Dis. 2018 Nov 22;218(suppl_5):S475-S485
pubmed: 30289506
Nat Med. 2020 Jun;26(6):842-844
pubmed: 32398875
Genome Biol. 2014;15(12):550
pubmed: 25516281
Nat Rev Microbiol. 2021 Mar;19(3):155-170
pubmed: 33116300
Bioinformatics. 2011 Jun 15;27(12):1739-40
pubmed: 21546393
Eur J Clin Pharmacol. 2020 Dec;76(12):1623-1630
pubmed: 32696234
Nat Cell Biol. 2019 Dec;21(12):1590-1603
pubmed: 31740775
Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9241-9243
pubmed: 32269081
Med Hypotheses. 2020 Nov;144:110218
pubmed: 33254525
Cell. 2021 Jan 7;184(1):120-132.e14
pubmed: 33382968
Lancet Digit Health. 2020 Dec;2(12):e667-e676
pubmed: 32984792
Genetics. 1996 May;143(1):95-102
pubmed: 8722765
Nat Commun. 2021 Mar 12;12(1):1660
pubmed: 33712587
J Virol. 2011 Jul;85(13):6381-9
pubmed: 21507972
Cell Discov. 2020 Mar 16;6:14
pubmed: 32194980
Cell. 2021 Jan 7;184(1):92-105.e16
pubmed: 33147445
PLoS Comput Biol. 2021 Mar 17;17(3):e1008805
pubmed: 33730015
Nature. 2021 Jun;594(7862):246-252
pubmed: 33845483
Nature. 2020 Jun;582(7813):469
pubmed: 32546811
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
J Infect Public Health. 2020 Sep;13(9):1187-1195
pubmed: 32773212
J Cell Biol. 2020 Oct 5;219(10):
pubmed: 32785687
PLoS Biol. 2020 Sep 8;18(9):e3000849
pubmed: 32898168
Virology. 2018 Dec;525:40-47
pubmed: 30240957
J Transl Med. 2020 Jun 3;18(1):222
pubmed: 32493510
Future Virol. 2020 Sep;15(9):577-593
pubmed: 33224264
Cell. 2002 Jul 26;110(2):143-51
pubmed: 12150923
EBioMedicine. 2021 Mar;65:103255
pubmed: 33676899
Nat Genet. 2013 Oct;45(10):1113-20
pubmed: 24071849
Cell. 2019 Jun 13;177(7):1888-1902.e21
pubmed: 31178118
Cancer Cell. 2019 Mar 18;35(3):457-472.e5
pubmed: 30773340
Cell. 2020 May 28;181(5):1036-1045.e9
pubmed: 32416070
Nucleic Acids Res. 2018 Jan 4;46(D1):D649-D655
pubmed: 29145629
BMJ. 2020 Nov 11;371:m4362
pubmed: 33177042
Mediators Inflamm. 2020 Oct 8;2020:3764515
pubmed: 33061826
Cell Host Microbe. 2018 Jun 13;23(6):819-831.e5
pubmed: 29902443
N Engl J Med. 2020 Nov 5;383(19):1813-1826
pubmed: 32445440
J Cell Biol. 2022 Nov 7;221(11):
pubmed: 36305789
Med. 2021 May 14;2(5):493-497
pubmed: 33899041
Proc Natl Acad Sci U S A. 2020 Nov 10;117(45):28336-28343
pubmed: 33082228
Nat Commun. 2018 Jun 29;9(1):2546
pubmed: 29959327
Nature. 2020 Jul;583(7816):469-472
pubmed: 32408336
J Med Virol. 2021 Sep;93(9):5260-5276
pubmed: 33851732
Mol Syst Biol. 2021 Nov;17(11):e10260
pubmed: 34709707
Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082
pubmed: 29126136
Nature. 2020 Jul;583(7816):459-468
pubmed: 32353859
Aging Cell. 2020 Oct;19(10):e13237
pubmed: 32955770
Nature. 2020 Oct;586(7827):113-119
pubmed: 32707573
Gastroenterology. 2020 May;158(6):1831-1833.e3
pubmed: 32142773

Auteurs

Lipika R Pal (LR)

Cancer Data Science Laboratory (CDSL), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.

Kuoyuan Cheng (K)

Cancer Data Science Laboratory (CDSL), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.
Center for Bioinformatics and Computational Biology, University of Maryland, College Park, MD, USA.

Nishanth Ulhas Nair (NU)

Cancer Data Science Laboratory (CDSL), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.

Laura Martin-Sancho (L)

Immunity and Pathogenesis Program, Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.

Sanju Sinha (S)

Cancer Data Science Laboratory (CDSL), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.
Center for Bioinformatics and Computational Biology, University of Maryland, College Park, MD, USA.

Yuan Pu (Y)

Immunity and Pathogenesis Program, Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.

Laura Riva (L)

Immunity and Pathogenesis Program, Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.

Xin Yin (X)

Immunity and Pathogenesis Program, Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.

Fiorella Schischlik (F)

Cancer Data Science Laboratory (CDSL), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.

Joo Sang Lee (JS)

Cancer Data Science Laboratory (CDSL), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.
Samsung Medical Center, Sungkyunkwan University School of Medicine, Suwon 16419, Republic of Korea.

Sumit K Chanda (SK)

Immunity and Pathogenesis Program, Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.

Eytan Ruppin (E)

Cancer Data Science Laboratory (CDSL), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.
Department of Computer Science, University of Maryland, College Park, MD, USA.

Classifications MeSH